Skip to main content
Retour
Watch Compare

Emergent BioSolutions Inc.

Qualité des données : 100%
EBS
NYSE Manufacturing Chemicals
7,96 €
▼ 0,49 € (-5,80%)
Cap. Boursière: 412,10 M
Prix
7,96 €
Cap. Boursière
412,10 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -19,77% annually over 5 years
Generating 156,80 M in free cash flow
P/E of 7,83 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,04%
Cash machine — converts 298,10% of earnings into free cash flow
Capital efficient — spends only 1,86% of revenue on capex

Croissance

Revenue Growth (5Y)
-19,77%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-28,81%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
9,40%
Au-dessus de la moyenne du secteur (-53,53%)
ROIC4,86%
Net Margin7,08%
Op. Margin13,47%

Sécurité

Debt / Equity
1,19
Au-dessus de la moyenne du secteur (0,31)
Current Ratio5,76
Interest Coverage1,69

Valorisation

PE (TTM|NTM|2027)
7,83 | 34,61 | 34,61
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,71
EV/EBITDA4,39
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E 7,8 -1,5
P/B 0,7 1,6
ROE % 9,4 -53,5
Net Margin % 7,1 -41,5
Rev Growth 5Y % -19,8 1,8
D/E 1,2 0,3

Objectif de Cours des Analystes

2 analystes
Buy
Actuel
7,96 €
+50.8%
Objectif
12,00 €
12,00 €
12,00 €
12,00 €
Prévisions
P/E Prévisionnel 34,61
BPA Prévisionnel 0,23 €
Croissance BPA (est.) -55,8%
CA Est. 892,00 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,23 €
0,23 € – 0,23 €
 892,00 M 1
FY2026 0,52 €
0,52 € – 0,52 €
 745,00 M 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 0,11 € -0,43 € -490,9%
Q32025 -0,12 € 1,06 € +984,2%
Q22025 -0,49 € 0,16 € +132,7%
Q12025 0,44 € 0,71 € +61,4%

ETFs Holding This Stock

AIFFX AIFFX
3,31% weight
ARIFX ARIFX
3,31% weight
BAHAX BAHAX
2,69% weight
BAFHX BAFHX
2,69% weight
ICPY logo ICPY Tweedy, Browne International Insider + Value ETF
1,91% weight
AIOOX AIOOX
1,67% weight
ARAOX ARAOX
1,67% weight
ARIOX ARIOX
1,67% weight
BINV BINV
1,67% weight
ACVDX ACVDX
1,52% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -28,81% Revenue Growth (3Y) -15,86%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -19,77% Earnings Growth (5Y) -30,91%
Profitability
Revenue (TTM) 742,90 M Net Income (TTM) 52,60 M
ROE 9,40% ROA 3,66%
Gross Margin N/A Operating Margin 13,47%
Net Margin 7,08% Free Cash Flow (TTM) 156,80 M
ROIC 4,86% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,19 Current Ratio 5,76
Interest Coverage 1,69 Asset Turnover 0,52
Working Capital 650,40 M Tangible Book Value 129,80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 7,83 Forward P/E 34,61
P/B Ratio 0,71 P/S Ratio 0,55
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4,39 Fwd EV/EBITDA N/A
Forward P/S 0,46 Fwd Earnings Yield 2,89%
FCF Yield 38,05%
Market Cap 412,10 M Enterprise Value 859,70 M
Per Share
EPS (Diluted TTM) 0,93 Revenue / Share 14,35
FCF / Share 3,03 OCF / Share 3,30
EPS CAGR (1Y) N/A EPS CAGR (5Y) -31,69%
EPS CAGR (10Y) -2,14%
Efficiency
CapEx / Revenue 1,86% FCF Conversion 298,10%
SBC-Adj. FCF 140,00 M Growth Momentum -9,04

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 742,90 M 1,04 B 1,05 B 1,12 B 1,79 B
Net Income 52,60 M -190,60 M -760,50 M -223,80 M 230,90 M
EPS (Diluted) 0,93 -3,60 -14,85 -4,47 4,27
Gross Profit — — 317,60 M 385,80 M —
Operating Income 100,10 M -108,70 M -726,40 M -172,70 M 352,60 M
EBITDA — — — — —
R&D Expenses 53,20 M 70,70 M 111,40 M 193,00 M 234,00 M
SG&A Expenses 186,10 M 308,00 M 368,40 M 340,30 M 348,40 M
D&A 95,80 M 108,80 M 125,10 M — —
Interest Expense 59,30 M 71,00 M 87,90 M 37,30 M 34,50 M
Income Tax 30,20 M 47,70 M 29,30 M 2,10 M 83,50 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,32 B 1,39 B 1,82 B 3,17 B 2,96 B
Total Liabilities 796,00 M 906,90 M 1,17 B 1,78 B 1,34 B
Shareholders' Equity 522,60 M 482,80 M 649,30 M 1,38 B 1,62 B
Total Debt 589,70 M 700,00 M 868,40 M 1,41 B 849,60 M
Cash & Equivalents 205,40 M 99,50 M 111,70 M 642,60 M 576,10 M
Current Assets 662,50 M 598,70 M 679,50 M 1,21 B 1,27 B
Current Liabilities 132,20 M 162,40 M 651,30 M 1,23 B 373,80 M